End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics-Reference-Cited by-同舟云学术

End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics

Published:2022-12-05 Issue:1 Volume:25 Page:
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Morales Annette Medina,Sreedhara Alavattam,Buecheler Jakob,Brosig Sebastian,Chou Danny,Christian Twinkle,Das Tapan,de Jong Isabella,Fast Jonas,Jagannathan Bharat,Moussa Ehab M.,Nejadnik M. Reza,Prajapati Indira,Radwick Allison,Rahman Yusra,Singh Shubhadra

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1208/s12248-022-00773-3.pdf

Reference128 articles.

1. Number of products and pipeline count per modality for commonly used surfactants. 22 December 2021.

2. Bam NB, Randolph TW, Cleland JL. Stability of protein formulations: investigation of surfactant effects by a novel EPR spectroscopic technique. Pharm Res. 1995;12(1):2–11.

3. Misono T, et al. Surface adsorption and micelle formation of polyoxyethylene-type nonionic surfactants in mixtures of water and hydrophilic imidazolium-type ionic liquid. J Oleo Sci. 2016;65(6):499–506.

4. Khan T, Mahler H-C, Kishore R. Key interactions of surfactants in therapeutic protein formulations: a review. Eur J Pharm Biopharm. 2015;97.

5. Bam NB, et al. Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J Pharm Sci. 1998;87(12):1554–9.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzymatic degradation pattern of polysorbate 20 impacts interfacial properties of monoclonal antibody formulations;European Journal of Pharmaceutics and Biopharmaceutics;2024-01

2. Comparison of the Protective Effect of Polysorbates, Poloxamer and Brij on Antibody Stability Against Different Interfaces;Journal of Pharmaceutical Sciences;2023-11

3. Not the Usual Suspects: Alternative Surfactants for Biopharmaceuticals;ACS Applied Materials & Interfaces;2023-07-14

4. Correction: End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics;The AAPS Journal;2023-01-11